Drug intelligence / Profile preview

selenium disulfide

Development stage
Approved
Lead developer
Sanofi
Modality
Small Molecules
Administration
Topical
01

Overview

Selenium disulfide is an **inorganic compound** used as a topical medication, primarily indicated for the treatment of **dandruff**, **seborrheic dermatitis**, and **tinea versicolor**. It works as a **keratolytic**, antifungal, cytostatic, and antimitotic agent by slowing down the growth and turnover of epithelial cells and inhibiting the growth of Malassezia fungi involved in these skin conditions. Its antifungal mechanism may involve interference with the cellular oxygen-eliminating systems of fungi, leading to increased reactive oxygen species and fungal death. It is most commonly formulated as shampoos and lotions, with concentrations ranging from 1% to 2.5%, and is available as both over-the-counter and prescription products. Selenium disulfide was first approved for medical use in 1951 and is on the WHO List of Essential Medicines. It is not considered safe for children under 2 years of age, and evidence for its use in pregnancy or breastfeeding is limited. Its use is mostly restricted to topical application, as systemic absorption is minimal unless applied to damaged skin[1][2][3][5][6].

Brand names
Selsun BlueDandrexSelsun Blue 2 in 1Selsun Blue Balanced TreatmentSelsun Blue Medicated TreatmentSelsun Blue Moisturizing TreatmentSelsebSelrx
Other names
selenium sulfideselenium disulphideselenium sulphideselenium sulfide, micronizedselenium sulphide, micronizedselenium(IV) disulfideselenium(IV) disulphideselenium(IV) sulfideselenium(IV) sulphideSelenii disulfidum
02

Targets

Malassezia speciesKRT (Keratin, type I cuticular Ha7)

Beyond the preview

Go deeper on selenium disulfide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on selenium disulfide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call